Berapakah harga Scilex Holding Company (SCLX)

Harga Scilex Holding Company (SCLX) adalah $5.61

Apakah topi pasaran Scilex Holding Company (SCLX)

Cap pasaran Scilex Holding Company (SCLX) adalah $47.65M

Scilex Holding Company (SCLX) Dividen

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.

Tahun	Dividen (diselaraskan untuk pemecahan saham)	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Dividen (diselaraskan untuk pemecahan saham)

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Tahun	Dividen	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Dividen

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Jumlah pembayaran dividen	Negara
Eli Lilly and Company LLY.US	215.00%	US
Johnson & Johnson JNJ.US	225.00%	US
AbbVie Inc. ABBV.US	53.00%	US
Roche Holding AG RO.SW	33.00%	CH
Merck & Co., Inc. MRK.US	223.00%	US

Syarikat

Jumlah pembayaran dividen

Negara